<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04099940</url>
  </required_header>
  <id_info>
    <org_study_id>VRAT- ATP</org_study_id>
    <nct_id>NCT04099940</nct_id>
  </id_info>
  <brief_title>Virtual Reality Avatar Therapy for People Hearing Voices</brief_title>
  <official_title>Virtual Reality Avatar Therapy for People Hearing Voices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Psychiatric University Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Psychiatric University Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hearing voices is probably the worst form of acoustic hallucinations; which can be
      experienced as severely disturbing and is influenced by diverse factors including the ability
      of the individual to influence and control the hallucinatory experience itself. In recent
      years virtual reality has become a treatment option. In the so-called AVATAR Therapy,
      patients with schizophrenia and acoustic hallucinations design a visual and auditory
      recreation (avatar) of the entity to which they attribute their hallucinations. Working with
      a therapist over the course of several sessions, participants change the avatar from
      controlling to benevolent. Avatar Therapy involves similar processes to learning and
      cognitive restructuring, comparable to other psychotherapeutic interventions. The
      investigators plan to conduct an interventional study using a cross-over design, to compare
      the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic
      hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group
      therapy aimed to improve social competence.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The investigators plan to conduct a single-blind, randomised, controlled trial in a cross-over design to assess the feasibility and efficacy of VRAT in patients with acoustic hallucinations, independent of the main diagnosis.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psychopathological Assessment</measure>
    <time_frame>Change: Baseline, 3, 6 weeks, 6 and 12 months]</time_frame>
    <description>Symptom Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychotic Symptoms</measure>
    <time_frame>Change: Baseline, 3, 6 weeks, 6 and 12 months]</time_frame>
    <description>Symptom Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insecurity- Self-confidence</measure>
    <time_frame>Change: Baseline, 3, 6 weeks, 6 and 12 months]</time_frame>
    <description>Symptom Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Psychosis</condition>
  <condition>Schizophrenia</condition>
  <condition>Schizo Affective Disorder</condition>
  <condition>Hearing Voices When No One is Talking (Symptom)</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Avatar Therapy (VRAT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the VRAT, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assertiveness Training Program (ATP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The ATP is a transdiagnostic cognitive behavioural treatment programme, which aims to increase self-confidence and social competence in patients with a psychiatric disorder.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual Reality Avatar Therapy (VRAT)</intervention_name>
    <description>The Virtual Reality Avatar Therapy (VRAT) is a Cognitive Behavioral Intervention, delivered through Virtual Reality.</description>
    <arm_group_label>Assertiveness Training Program (ATP)</arm_group_label>
    <arm_group_label>Virtual Reality Avatar Therapy (VRAT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Assertiveness Training Program (ATP)</intervention_name>
    <description>The Assertiveness Training Program (ATP) is a Cognitive Behavioral Intervention, delivered as group therapy.</description>
    <arm_group_label>Assertiveness Training Program (ATP)</arm_group_label>
    <arm_group_label>Virtual Reality Avatar Therapy (VRAT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consistent acoustic hallucinations, with the presence of voices for at least two
             months.

          -  Participants are competent to give informed consent, as determined by the referring
             physician or psychiatrist.

          -  German language proficiency as a native speaker or level B1 Common European Framework
             of Reference for Languages (CEFRL)

        Exclusion Criteria:

          -  Current neurological disorder.

          -  Current substance use or withdrawal.

          -  Concomitant group psychotherapeutic intervention.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephan T. Egger, MD</last_name>
    <phone>+41523049340</phone>
    <email>stephan.egger@puk.zh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychiatrische Universitätsklinik Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, Emsley R, Garety PA. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018 Jan;5(1):31-40. doi: 10.1016/S2215-0366(17)30427-3. Epub 2017 Nov 23. Erratum in: Lancet Psychiatry. 2017 Nov 29;:.</citation>
    <PMID>29175276</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>March 2, 2020</last_update_submitted>
  <last_update_submitted_qc>March 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Psychiatric University Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Stephan T. Egger</investigator_full_name>
    <investigator_title>Senior Psychiatrists</investigator_title>
  </responsible_party>
  <keyword>Hearing Voices, Virtual Reality Avatar Therapy, Cognitive Behavioural Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

